Page 221 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.2. Trends in prostate cancer incidence rates (per 100,000 unless otherwise stated) (continued)
Author Database Groups 1980-84 1985-89 1990-94 1995-99 2000-04 2005- Statistical Notes
Year 10 analysis
PMID
LAC/USC Localized -1.7 P<0.05 Additional
CSP Regional (−4.2, (for difference information
Metastatic 1) between is
Unstaged 8.9 (1.3, stage groups presented
Percent annual 11.7) for the linear in Figure 2
change of the -0.9 trend over yr, of the
stage-specific (−5.5, 1976-88) paper.
incidence rate 4)
[Asian] -4.6
(−10.7,
2.0)
(1976-
88)
Tumor
characteristics –
Gleason score
and histological
grade
17
Hankey SEER Well diff. NA 3.2 (2.4, -20.4 Annual Additional
1999 4.0) (−27.3, percentage information
10379964 Moderately diff. 9.1 (7.6, (1973-92) −12.9) changes is
10.6) 26.9 (19.7, (1992-95) calculated presented
Poorly diff./undiff. (1973-88) 34.5) -9.3 (-13.7, from joinpoint in Figure 4
5.8 (5.3, (1988-92) -4.7) regression of the
Unknown 6.3) 18.3 (8.0, (1992-95) (95% CI). paper.
(1973-90) 29.6) -14.7
Annual -6.3 (-8.1, (1990-92) (−17.8,
percentage -4.5) 9.5 (-5.4, −11.4)
change of the (1973-88) 26.7) (1992-95)
age-standardized (1988-92) -13.4
(1970 US (−25.2, 0.3)
standard) (1992-95)
incidence rates

C-28